The Tumor Mutation Burden in Gastro-entero-pancreatic-neuroendocrine Tumors
Not Applicable
Completed
- Conditions
- Neoplasms
- Registration Number
- KCT0007980
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients diagnosed with gastro-entero-pancreatic-neuroendocrine tumors
Exclusion Criteria
Patients did not evaluated NGS
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor mutation burden
- Secondary Outcome Measures
Name Time Method PD-L1 expression